Infectious Diseases Clinical Research Unit (CRU)
The Infectious Diseases Clinical Research Unit conducts single and multi-centre investigator and industry-initiated studies.
The studies vary in type such as:
- Testing the efficacy and safety of new or novel drug treatments
- Observational studies that aim to collect data from populations, and typically involve large numbers of participants followed for many years
- Specifics of a group at a single point in time
The unit is based at The Alfred and enjoys close links with other primary and tertiary health care providers with similar interests, including:
- Melbourne Sexual Health Centre
- Royal Melbourne Hospital
- Monash Health and inner city practices
- Prahran Market, Centre and Northside Clinics
We also collaborate closely with the Burnet Institute, Monash University, The Doherty Institute, Baker Heart & Diabetes Institute, and the Kirby Institute (Sydney).
- International multi-site clinical trial for new treatments in Infectious Diseases including HIV, Hepatitis C, Influenza and Clostridium Difficile
- Clinical trials in collaboration with the Doherty Institute in the field of HIV Cure
- Leading or participating in multi-site surveillance and observational studies such as, FluCAN (The Influenza Complications Alert Network) and the Australian HIV Observational Database
- Other studies in General Infectious Diseases as a member of the Australian Society for Infectious Diseases Clinical Research Network
- Support for research implementation, monitoring and ethics applications for our collaborators
- Other related infectious diseases clinical research
If you are interested in participating in a clinical study, register your interest by contacting the Clinical Research Unit.
You can also be placed on a contact list for future studies.
All potential participants in a study are provided with a Patient Information and Consent Form and are encouraged to talk to either their physician or to a member of the Clinical Research Unit before agreeing to be involved in a study.
This trial is studying whether taking an antiviral that has been used to treat influenza and also has activity against COVID will also help people recover from COVID and clear the virus more quickly than a placebo or sugar tablet. The antiviral medicine is called favipiravir.Find out more